Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Shares Outstanding (2018 - 2025)

Neurogene (NGNE) has disclosed Shares Outstanding for 3 consecutive years, with $41.9 million as the latest value for Q3 2020.

  • For the quarter ending Q3 2020, Shares Outstanding rose 48.81% year-over-year to $41.9 million, compared with a TTM value of $41.9 million through Sep 2020, up 48.81%, and an annual FY2019 reading of $38.0 million, up 61.43% over the prior year.
  • Shares Outstanding was $41.9 million for Q3 2020 at Neurogene, up from $38.5 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $41.9 million in Q3 2020 and bottomed at $101927.0 in Q3 2019.
  • Average Shares Outstanding over 3 years is $27.5 million, with a median of $23.5 million recorded in 2018.
  • The sharpest move saw Shares Outstanding changed 0.0% in 2019, then surged 63.51% in 2020.
  • Year by year, Shares Outstanding stood at $23.5 million in 2018, then surged by 61.43% to $38.0 million in 2019, then grew by 10.21% to $41.9 million in 2020.
  • Business Quant data shows Shares Outstanding for NGNE at $41.9 million in Q3 2020, $38.5 million in Q2 2020, and $38.4 million in Q1 2020.